VISTIN PHARMA ASA

0661 OSLO

Finances

Return on Equity

−1,73 %

Current Ratio

1,35

Debt-to-Equity Ratio

0,06

Key figures (NOK)	2022	2021	2020	2019
Revenue	304 852 000	278 623 000	253 906 000	228 129 000
Net Income	−4 715 000	24 866 000	−96 954 000	66 074 000
Total Assets	407 214 000	333 146 000	321 915 000	504 162 000
Total Equity	273 263 000	275 768 000	272 405 000	413 395 000

Income (NOK)	2022	2021	2020	2019
Revenue	304 852 000	278 623 000	253 906 000	228 129 000
Expenditure	310 948 000	245 373 000	208 350 000	211 359 000
Operating Profit	−6 096 000	33 250 000	45 556 000	16 770 000
Financial Income	9 554 000	6 067 000	14 066 000	72 038 000
Financial Costs	9 466 000	7 322 000	183 893 000	4 766 000
Financial Balance	88 000	−1 255 000	−169 827 000	67 272 000
Earnings Before Tax	−6 008 000	31 995 000	−124 271 000	84 042 000
Tax	−1 293 000	7 129 000	−27 317 000	17 968 000
Net Income	−4 715 000	24 866 000	−96 954 000	66 074 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	248 032 000	195 315 000	180 389 000	109 533 000
Total Current Assets	159 182 000	137 831 000	141 526 000	394 629 000
Total Assets	407 214 000	333 146 000	321 915 000	504 162 000
Total Retained Equity	22 033 000	24 538 000	−996 000	95 649 000
Total Equity	273 263 000	275 768 000	272 405 000	413 395 000
Total Long-Term Debt	16 155 000	16 343 000	17 306 000	17 531 000
Total Current Debt	117 795 000	41 035 000	32 204 000	73 238 000
Total Equity and Debt	407 213 000	333 146 000	321 915 000	504 164 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	287 675 000	275 812 000	253 159 000	227 186 000
Other Income	17 177 000	2 811 000	747 000	943 000
Revenue	304 852 000	278 623 000	253 906 000	228 129 000
Cost of Goods Sold	138 064 000	96 097 000	73 288 000	84 113 000
Salary Costs	78 972 000	73 426 000	72 499 000	69 582 000
Depreciation	12 280 000	10 609 000	9 623 000	8 956 000
Impairment	0	0	0	0
Expenditure	310 948 000	245 373 000	208 350 000	211 359 000
Operating Profit	−6 096 000	33 250 000	45 556 000	16 770 000
Financial Income	9 554 000	6 067 000	14 066 000	72 038 000
Financial Costs	9 466 000	7 322 000	183 893 000	4 766 000
Financial Balance	88 000	−1 255 000	−169 827 000	67 272 000
Dividends	0	0	0	0
Net Income	−4 715 000	24 866 000	−96 954 000	66 074 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	28 601 000	27 858 000	35 128 000	7 733 000
Real Eastate	42 847 000	103 268 000	77 132 000	41 248 000
Machinery and Plant Facilities	175 477 000	59 334 000	62 366 000	55 513 000
Fixtures	1 107 000	4 855 000	5 763 000	5 039 000
Total Tangible Assets	219 431 000	167 457 000	145 261 000	101 800 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	248 032 000	195 315 000	180 389 000	109 533 000
Stock	83 446 000	42 907 000	31 788 000	24 107 000
Total Investments	0	0	0	0
Cash, Bank	1 435 000	35 746 000	77 036 000	319 672 000
Total Current Assets	159 182 000	137 831 000	141 526 000	394 629 000
Total Assets	407 214 000	333 146 000	321 915 000	504 162 000
Total Equity	273 263 000	275 768 000	272 405 000	413 395 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	16 155 000	16 343 000	17 306 000	17 531 000
Creditors	25 906 000	20 808 000	17 893 000	23 612 000
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	91 889 000	20 227 000	14 311 000	45 830 000
Total Current Debt	117 795 000	41 035 000	32 204 000	73 238 000
Total Equity and Debt	407 213 000	333 146 000	321 915 000	504 164 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−1,73 %	9,02 %	−35,59 %	15,98 %
Debt-to-Equity Ratio	0,06	0,06	0,06	0,04
Operating Profit Margin	−2 %	11,93 %	17,94 %	7,35 %
Current Ratio	1,35	3,36	4,39	5,39
Quick Ratio	4,63	−73,63	340,21	8,03
Equity Ratio	0,67	0,83	0,85	0,82
Gross Profit Margin	54,71 %	65,51 %	71,14 %	63,13 %